• Loading stock data…

Valneva annonce des résultats positifs de Phase 3 concernant l’immunogénicité de son candidat vaccin contre le chikungunya chez les adolescents

Last Updated on November 13, 2023 by


Print Friendly, PDF & Email
Spread the word

Reader Interactions

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Generated by Feedzy
%d bloggers like this: